Walleye Capital
AGL icon

Walleye Capital’s Agilon Health AGL Stock Holding History

Walleye Capital’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.65M Buy
+15,440
New +$1.01M 0.01% 1691
2025
Q4 		– Sell
-563
Closed -$14.5K – 4510
2025
Q3 		$14.5K Sell
563
-1,510
-73% -$57K ﹤0.01% 4244
2025
Q2 		$119K Buy
+2,073
New +$166K ﹤0.01% 3689
2024
Q4 		– Sell
-8,625
Closed -$521K – 4771
2024
Q3 		$847K Buy
8,625
+1,089
+14% +$141K ﹤0.01% 2817
2024
Q2 		$1.23M Buy
7,536
+7,389
+5,027% +$1.05M ﹤0.01% 2619
2024
Q1 		$22.3K Sell
147
-103
-41% -$17.1K ﹤0.01% 4899
2023
Q4 		$78.6K Buy
+250
New +$90.5K ﹤0.01% 4149
2022
Q1 		– Sell
-664
Closed -$448K – 2255
2021
Q4 		$448K Buy
+664
New +$404K 0.01% 1045

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Walleye Capital's AGL Position: Q2 2026 in Review

Walleye Capital opened a new position in Agilon Health (AGL) in Q2 2026: 15,440 shares worth $1.65M. The stake represents 0.01% of the portfolio and ranks #1691 among its holdings. This is a return to the name: Walleye Capital previously reported a position in AGL as recently as Q3 2025.

Walleye Capital first reported a position in AGL in Q4 2021 and has held it in 8 quarters since. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Walleye Capital held 15,440 shares of Agilon Health worth $1.65M as of Q2 2026.
  • Agilon Health was a new Walleye Capital position in Q2 2026.
  • Agilon Health made up 0.01% of Walleye Capital's portfolio in Q2 2026, its #1691 holding.
  • Walleye Capital first reported a position in Agilon Health in Q4 2021 and has held it in 8 quarters since.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.